PDX models have been successfully established for a variety of cancers, including breast cancer, colorectal cancer, lung cancer, pancreatic cancer, and ovarian cancer, among others. These models allow researchers to study the unique characteristics and treatment responses of different cancer types, contributing to personalized medicine approaches.
